Precision Medicine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Precision Medicine
Jul 19, 2024, 22:57 |
Blog
Solange Peters will be the keynote speaker for LUNGevity Foundation’s ILCSC24
Amy C. Moore, VP, Global Engagement and Research Partnerships at LUNGevity Foundation, shared a post…
Jul 19, 2024, 12:31 |
Insight
Genetic Testing in Men With mCRPC
William Oh shared a post on LinkedIn about a recent paper by Pedro Barata et…
Jul 19, 2024, 09:15 |
Blog
Maria Teresa Voso's insights on MDS diagnosis and management - EHA
European Hematology Association (EHA) shared a post on X: " New podcast out! Join Professor…
Jul 16, 2024, 13:20 |
Blog
Mya Tran: Another year of many developments in precision medicine
Mya Tran, Thoracic Clinical Pharmacist, PharmD, BCOP, at Indiana University Health - Simon Comprehensive Cancer Center,…
Jul 14, 2024, 13:22 |
Blog
Opportunities to improve outcomes by measuring the quality of precision oncology - Marathon of Hope Cancer Centres Network
Yvonne Bombard, Canada Research Chair at Unity Health Toronto, shared a post by Marathon of…
Jul 13, 2024, 11:09 |
Insight
Promising results from a Phase 1 clinical trial - Chordoma Foundation
Chordoma Foundation made the following post on X: "Promising results have emerged from a Phase…
Jul 11, 2024, 14:06 |
Insight
MASCC webinar on Precision Medicine for Hormone Receptor Positive Breast Cancer
MASCC shared on X: “Join us on July 29 for a MASCC webinar on Precision…
Jul 10, 2024, 08:35 |
Insight
Whole Genome Sequencing Improves Pediatric Cancer Care - Inside Precision Medicine
Inside Precision Medicine made the following post on X: "Whole Genome Sequencing Improves Pediatric Cancer Care…
Jul 10, 2024, 07:24 |
Drugs
How well sotorasib with or without panitumumab can treat patients with advanced Solid Tumors - ECOG-ACRIN Cancer Research Group
ECOG-ACRIN Cancer Research Group shared on X: "ComboMATCH/EAY191-E5 tests how well sotorasib with or without…
Jul 6, 2024, 02:00 |
Blog
The NCI PREVENT Cancer Preclinical Drug Development Program - NCI Division of Cancer Prevention
NCI Division of Cancer Prevention shared on LinkedIn: “Application deadline Monday! Are you someone actively…
Jul 5, 2024, 16:21 |
Blog
Latest episodes from the Precision Medicine podcast
Karan Cushman, Chief Vision Officer at Cushman Creative shared on LinkedIn: "Happy 4th, Precision Medicine…
Jul 5, 2024, 04:53 |
Blog
Angela Lamarca: First session on biliary cancer at Precision-BTC-Network
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:…
Jul 4, 2024, 13:06 |
Blog
Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh
Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X: “The NTACT residual disease test,…
Jul 4, 2024, 12:15 |
Blog
Angela Lamarca: We MUST validate innovate biomarkers in clinical trials
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on…
Jul 4, 2024, 10:04 |
Blog
Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.
Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and…
Jul 1, 2024, 15:09 |
Blog
Yüksel Ürün: Did you know the FDA approved cancer drugs target fewer than 200 proteins?
Yüksel Ürün shared a post on X: “Did you know the FDA approved cancer drugs…
Jun 27, 2024, 03:32 |
Blog
Elena Rizova is the new journey as the Chief Medical Officer at Stallergenes Greer
Elena Rizova, EVP, Chief Medical Officer at Stallergenes Greer, made the following post on LinkedIn:…
Jun 25, 2024, 03:43 |
Insight
The potential of precision medicine in gynaecologic cancers - ESMO
The European Society for Medical Oncology (ESMO) shared on LinkedIn: "ESMOGynae24: The combination of comprehensive…
Jun 25, 2024, 03:26 |
Blog
Vivek Subbiah: Such a delight to have our paper published in a journal with the highest impact factor
Vivek Subbiah shared on LinkedIn: "2023 Impact factors for all journals are out!!! CA: A Cancer…
Jun 24, 2024, 15:24 |
Blog
Jill Barnholtz-Sloan: New AI tool for analyzing images of Brain Tumors to predict their methylation state
Jill Barnholtz-Sloan, CBIIT Acting Director at National Cancer Institute, shared a post on X: “Here’s a…
Jun 23, 2024, 17:29 |
Insight
Carolina Belmar López: ESMO updates the recommendations for NGS with advanced cancers
Carolina Belmar López, Laboratory Director of Oncogenomics, shared on LinkedIn: . "ESMO updates the recommendations…
Jun 22, 2024, 15:13 |
Drugs
Vivek Subbiah: Another FDA approval to adagrasib plus cetuximab for KRAS G12C-mutated colorectal cancer
Vivek Subbiah shared on LinkedIn: "It's Friday and time for another FDA approval! FDA grants…
Jun 22, 2024, 01:35 |
Blog
Douglas Flora: Our shared mission of AI, to fight cancer, drives us forward every day
Douglas Flora recently shared a post on LinkedIn: "Our shared mission—to harness the power of…
Jun 20, 2024, 01:53 |
Insight
Miguel Bronchud: ESMO recommends performing tumour NGS to detect tumour-agnostic alterations in patients with metastatic cancers
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “2024- ESMO of course recommends…
Jun 20, 2024, 01:37 |
Insight
Torrie Fields: Let’s make supportive cancer care the standard of care
Torrie Fields, Founder and Chief Executive Officer at TFA Analytics, shared a post by Ramy…
Jun 15, 2024, 16:02 |
Dialogues
Oncodaily Talks: Dialogue with Giuseppe Curigliano, hosted by Chandler Park
OncoDaily Talks gathers people worldwide to discuss challenges in cancer care. We share creative solutions…
Jun 15, 2024, 01:18 |
Blog
Karen Knudsen: All in against cancer with my friends from Coaches vs. Cancer
Karen Knudsen shared on LinkedIn: “All in against cancer with my friends from Coaches vs. Cancer…
Jun 14, 2024, 00:19 |
Blog
Yemisi Osakwe: Empowering Precision Medicine, the Future of Cancer Care in Nigeria
Yemisi Osakwe, Research Operations Advisor at Marcelle Ruth Cancer Center, shared a post on LinkedIn: “Empowering…
Jun 13, 2024, 10:46 |
Blog
Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference
Amy C. Moore, VP of Global Engagement and Patient Partnerships, LUNGevity Foundation, shared a post…
Jun 11, 2024, 12:56 |
Insight
Radiopharmaceuticals are revolutionizing the way we approach diagnosis, medical treatment, and patient care - Allucent
Allucent recently shared a post on LinkedIn: "Radiopharmaceuticals are gaining significant attention as this treatment…
Jun 11, 2024, 11:49 |
Blog
Cristian Massacesi: Very much enjoyed being part of the Endpoints panel at ASCO2024
Cristian Massacesi, Chief Medical Officer and Oncology Chief Development Officer at AstraZeneca, posted on LinkedIn:…
Jun 10, 2024, 10:10 |
Societies
Omar El-Khatib: The first ASCO experience is definitely something I will remember for a long time
Omar El-Khatib, Medical Lead Breast Cancer at Novartis Gulf, shared a post on LinkedIn: "The…
Jun 10, 2024, 04:49 |
Blog
Ibrahim Halil Sahin: I discussed the findings of neoadjuvant rectal cancer study of Dostarlimab with Alison Kanski
Ibrahim Halil Sahin Assistant Professor of Medicine Division of Hematology/Oncology at University of Pittsburgh School of…
Jun 9, 2024, 09:45 |
Societies
Chandler Park: A fun discussion at ASCO24 with David O’Malley
Chandler Park recently shared on X: "Dr. David O’Malley and I have a fun discussion…
Jun 7, 2024, 10:04 |
Insight
Jacob Adashek: Tissue is not the issue
Jacob Adashek recently shared a post by the National Cancer Institute (NCI) on Linkedin, adding:…
Jun 6, 2024, 06:30 |
Blog
Ahmad Tarhini: Chatting with Patrick Hwu about the latest advances in melanoma management
Ahmad Tarhini, Director, Cutaneous Clinical and Translational Research at Moffitt Cancer Center and Research Institute,…
Jun 5, 2024, 10:12 |
Societies
Samin Saeed: My first time at ASCO
Samin Saeed, Chief Medical Officer at Random42 Scientific Communication, shared a post on LinkedIn: "At…
Jun 3, 2024, 22:34 |
Blog
Daniel Sumarriva: Finally had a chance to meet Sanjay Juneja in person here at ASCO24
Sanjay Juneja, Editorial Board Member at AI in Precision Oncology, shared a post by Daniel Sumarriva, Senior…
Jun 1, 2024, 14:46 |
Societies
15 Posts From ASCO24 Day 1 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
May 28, 2024, 05:12 |
Blog
Through the NAVIGATE program, veterans will get easier access to promising new cancer treatments - NCI
National Cancer Institute (NCI) shared the following on LinkedIn: “A partnership between the National Cancer…
May 26, 2024, 08:19 |
Insight
Andrei Nikiforchin: Our SENTRY trial is finally out
Andrei Nikiforchin, Surgical Oncology Researcher, Expert Consultant of the Online Help Desk for Cancer Patients…
May 23, 2024, 12:31 |
Blog
Join four top experts to discuss Post-AACR Spatial Biology Trench and Decoding Cancer Insights - Akoya Biosciences
Akoya Biosciences shared a post on LinkedIn: “How is spatial biology influencing the trajectory of…
May 22, 2024, 11:01 |
Blog
Josh Atkins: Identifying Proteomic Risk Factors
Josh Atkins, Senior Cancer Genomic Epidemiologist at the Nuffield Department of Population Health of Oxford…
May 22, 2024, 09:09 |
Blog
Paolo Tarantino: Mark your calendars for PER’s 6th Annual Precision Medicine Symposium
Paolo Tarantino made the following post on X: “Mark your calendars for PER’s 6th Annual Precision…
May 20, 2024, 14:34 |
Blog
Evolving Concepts in Meningioma Management in the Era of Genomics - ACS Journal Cancer
ACS Journal Cancer shared the following on X: "This new review article from Mass General…
May 20, 2024, 00:34 |
Insight
Douglas Flora: Post-AACR Spatial Biology Trends and Decoding Cancer Insights
Douglas Flora shared a post on LinkedIn: “Fireside Chat: Post-AACR Spatial Biology Trends and Decoding Cancer…
May 15, 2024, 09:25 |
Blog
Christos Tsagkaris: From tobacco control to precision medicine and citizenship
Christos Tsagkaris, Social Media Editor at JBI Evidence Implementation, shared a post on LinkedIn: "Last but…
May 14, 2024, 12:51 |
Blog
Vivek Subbiah: About time for precision immunotherapy
Vivek Subbiah shared a post on LinkedIn: “Sharing our editorial: Rationalizing rules for immunotherapy combination trials:…
May 14, 2024, 09:19 |
Blog
Vivek Subbiah: Picking that needle in haystack --> ROS1 fusion in Glioblastoma
Quoting Vivek Subbiah on X: “Picking that needle in haystack --> ROS1 fusion in Glioblastoma. Striking response…
May 14, 2024, 07:15 |
Blog
Andrea Necchi: Optimizing the use of NGS in pts with urothelial carcinoma
Andrea Necchi, Associate Professor at Vita-Salute San Raffaele University, shared on X: “Optimizing the use…
May 11, 2024, 11:32 |
Blog
Vivek Subbiah: Future of early-phase drug development and precision medicine is bright at Gustave Roussy Cancer Center!
Vivek Subbiah shared a post by Adrien Mouren, on X and added: "Future of early-phase…
May 9, 2024, 16:48 |
Blog
Estela Rodriguez: At the heart of every conference there is a director of the orchestra
Carmen Calfa, Breast Oncologist at Sylvester Comprehensive Cancer Center, shared a post by Estela Rodriguez on…
May 7, 2024, 15:35 |
Insight
Arndt Vogel: Excellent summary on precision medicine in HCC
Arndt Vogel shared on X: "Precision treatment in advanced HCC. Excellent summary on precision medicine…
May 7, 2024, 15:28 |
Blog
Estela Rodriguez: Sylvester Comprehensive Cancer Center discusses nutrition and exercise interventions for cancer management
Estela Rodriguez shared on X/Twitter: "Sylvester Comprehensive Cancer Center discusses nutrition and exercise interventions for cancer…
May 7, 2024, 13:00 |
Insight
Carmen Calfa: Let’s keep our fingers on the pulse - QOL and PROs matter!
Carmen Calfa, Medical Director of Clinical Operations and Breast Oncologist at Sylvester Comprehensive Cancer Centre,…
May 7, 2024, 11:33 |
Blog
Douglas Flora: The research you’ve performed, and published is changing the way cancer patients are treated around the world
Douglas Flora shared a post by Jaime Grund, Director of St. Elizabeth Healthcare, on LinkedIn: "Patients are safer…
May 4, 2024, 11:45 |
Blog
Trish Boh: St. Elizabeth Healthcare’s Precision Medicine Pharmacogenomic Team won the Innovation in Oncology Award
Trish Boh, Directors at St. Elizabeth Healthcare, shared on LinkedIn: "We’re so proud! In March,…
May 3, 2024, 17:25 |
Cancer Types
Susanna F. Greer: Planting a new seed for breast cancer research
Susanna F. Greer, Chief Scientific Officer at the V Foundation, published the following newsletter on…
May 2, 2024, 23:45 |
Insight
Aakash Desai: Insights into mNSCLC Management through a Global Clinician Survey
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared a post on…
May 2, 2024, 23:11 |
Blog
Vivek Subbiah: My first time inside Gustave Roussey in Paris France
Vivek Subbiah shared a post on LinkedIn: “My first time inside Gustave Roussey in Paris France.…
May 1, 2024, 20:07 |
Blog
Vivek Subbiah: Looking forward to delivering the keynote at the esteemed PRISM center in Paris
Vivek Subbiah shared a post on LinkedIn: “Just landed in Paris! Looking forward to delivering…
May 1, 2024, 19:47 |
Blog
Donnie Rizzo: A major leap forward in the field of Digital Pathology and AI
Donnie Rizzo, Global Director at Pathology and Oncology at Quest Diagnostics, made the following post…
Apr 30, 2024, 12:48 |
Insight
CAGLA's Marc Matrana won the very prestigious Ochsner Academic award
Marc Matrana, System Director of Precision Medicine, shared a post by Cancer Advocacy Group of…
Apr 29, 2024, 15:30 |
Insight
Nicola Ferrari: Principles and therapeutic applications of adaptive immunity
Nicola Ferrari, Translational Science Lead at AstraZeneca, made the following post on LinkedIn: "Principles and…
Apr 27, 2024, 11:47 |
Blog
Dive deep into the world of lung cancer biomarker testing with Bruna Pellini and Semir Vranić - Precision Oncology CONNECT
Precision Oncology CONNECT shared a post on LinkedIn: “Dive deep into the world of lung…
Apr 26, 2024, 12:00 |
Blog
Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli
Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…
Apr 25, 2024, 20:18 |
Positive
Vivek Subbiah: HUGE MILESTONE in all of medicine and a huge win for patients and families with sickle cell disease and β-Thalassemia
Quoting Vivek Subbiah's post on X/Twitter: "Hot off the press! HUGE MILESTONE in all of…
Apr 24, 2024, 14:51 |
Blog
Jemma Arakelyan: Just completed the ESMO Advanced Course on lung cancer
Jemma Arakelyan, CEO at the Institute of Cancer and Crisis, shared a post on LinkedIn: "Just…
Apr 23, 2024, 20:22 |
Blog
Chandler Park: What a FUN precision medicine and immunotherapy meeting at Cleveland Clinic
Chandler Park, Kentucky Physician Representative of the ASCO State Executive Council, shared on LinkedIn: "What a…
Apr 23, 2024, 18:57 |
Insight
New Paper Alert! Identifying a New EGFR Germline Mutation in Lung Adenocarcinoma: A Case Report and Review of the Literature
Identifying a New EGFR Germline Mutation in Lung Adenocarcinoma: A Case Report and Review of…
Apr 23, 2024, 12:12 |
Societies
Vivek Subbiah: Fantastic overview of Molecular Tumor Boards - MTB 101 and in-depth thought-provoking lecture by the amazing Ben Westphalen
Vivek Subbiah shared a post on X: "Fantastic overview of Molecular Tumor Boards - MTB…
Apr 23, 2024, 11:34 |
Blog
Vivek Subbiah: What a beautiful venue for a terrific meeting - the Italian Summit of Precision Oncology
Vivek Subbiah shared a post on X: "American Academy of Rome! What a beautiful venue…
Apr 22, 2024, 17:53 |
Insight
Andrei Nikiforchin: Our SENTRY trial results are now published in Clinical Oncology
Andrei Nikiforchin, Surgical Oncology Researcher at Mercy Medical Center, Baltimore, shared a post on LinkedIn: “What…
Apr 21, 2024, 10:09 |
Blog
Arun Azad: Pleased to share our latest work published in Urologic Oncology focusing on precision medicine in prostate cancer
Arun Azad, Consultant Medical Oncologist at Peter MacCallum Cancer Centre, shared on X/Twitter: ''Pleased to…
Apr 17, 2024, 17:23 |
Blog
Vivek Subbiah: Should we consider them 2nd generation PARP inhibitors or a completely NEW class of drugs?
Vivek Subbiah shared a post on X: "More than a dozen PARP1 selective drugs in different…
Apr 13, 2024, 09:17 |
Societies
30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…
Apr 12, 2024, 16:21 |
Societies
Vivek Subbiah: Where does the AACR24 Plenary Chair work with the ASCO Plenary Chair?
Vivek Subbiah shared a post on LinkedIn: "Where does the American Association for Cancer Research AACR24 Plenary…
Apr 11, 2024, 17:43 |
Societies
Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study - ASCO
American Society of Clinical Oncology (ASCO) shared a post LinkedIn: “Mark your calendars for our…
Apr 10, 2024, 08:53 |
Insight
Vivek Subbiah: Cell atlas projects have contributed to our understanding of cancers
Vivek Subbiah shared on X/Twitter: "We have learned a lot from cell atlas projects -…
Apr 8, 2024, 07:42 |
Insight
Pashtoon Kasi: Wondered how it looks when your own immune cells kill cancer?
Quoting Pashtoon Kasi, Director of Colon Cancer Research and Precision Medicine Research for Liquid Biopsies…
Apr 5, 2024, 16:38 |
Insight
Roberto Leon-Ferre: The role of immune activation on the prognosis of early TNBC if chemotherapy is not given
Roberto Leon-Ferre, Medical Oncologist at Mayo Clinic, shared on their X/Twitter: ''What is the role…
Apr 5, 2024, 08:35 |
Insight
Bishal Gyawali: Why 'number of cancer drugs approved' is a poor surrogate for measuring policy success
Alvaro Carrascal, Assistant Professor at University at Albany School of Public Health, shared a post…
Apr 5, 2024, 02:08 |
Blog
Vivek Subbiah: A real-life superhero
Vivek Subbiah shared on LinkedIn: “Want to meet a real-life superhero? Such a delight meeting Mike,…
Apr 3, 2024, 19:25 |
Career
Bishoy Faltas: Thrilled to take on this new role as Chief Research Officer of the Englander Institute for Precision Medicine
Bishoy Faltas, Chief Research Officer at Englander Institute for Precision Medicine, shared a post by…
Apr 2, 2024, 12:50 |
Blog
Antonio Passaro: Key milestones in cancer biomarker research and future avenues for enhancing the management of patients with solid tumors
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared a post on LinkedIn:…
Mar 31, 2024, 14:23 |
Blog
Dana-Farber Cancer Institute: Five Dana-Farber scientists have been chosen to receive Wong Family Awards in Translational Oncology for fiscal year 2024
Dana-Farber Cancer Institute posted on LinkedIn: "Five Dana-Farber scientists have been chosen to receive Wong…
Mar 24, 2024, 13:47 |
Career
Jean-Charles Soria: Thank you to my American Association for Cancer Research colleagues for this humbling vote of confidence
Jean-Charles Soria, SVP and Oncology Therapeutic Area Head, shared Amgen Oncology's post on LinkedIn and…
Mar 20, 2024, 16:11 |
Blog
On March 21st let's talk about Anal Cancer
Anal Cancer Awareness Day Anal cancer is one of the less discussed cancer types. It…
Mar 20, 2024, 14:34 |
Blog
Dive into the world of Precision Medicine this Myeloma and Colorectal Cancer Awareness Month - FDA Oncology
Quoting FDA Oncology on X: "Dive into the world of Precision Medicine this Myeloma and…
Mar 18, 2024, 22:51 |
Blog
Learn how we're transforming cancer care by bringing the right treatments to the right patient at the right time - MCW Cancer Center
MCW Cancer Center made the following post on X: 'Our physicians are leaders in Innovation…
Mar 18, 2024, 10:20 |
Blog
Zephyr AI Secures $111M In Series A To Advance Precision Medicine - Slice of Healthcare
Quoting Slice of Healthcare on LinkedIn: "Zephyr AI Secures $111M In Series A To Advance…
Mar 10, 2024, 21:03 |
Blog
Vivek Subbiah: Research should be standard-of-care and standard-of-care should be research
Vivek Subbiah recently posted on LinkedIn: "Yes! “Research should be standard-of-care and standard-of-care should be research”!!!…
Mar 5, 2024, 16:04 |
Blog
Pashtoon Kasi leads the peer ranked "Top 10 Voices in GI Oncology on X" by LARVOL
LARVOL/X recently shared the results of peer survey on "Top Voices in GI Oncology on…
Mar 3, 2024, 17:30 |
Insight
Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders
Marlene Thomas, Head of CGP Portfolio Strategy at Roche, shared on LinkedIn: "I want to…
Feb 19, 2024, 17:17 |
Career
Stacie Lindsey: We are thrilled that the ESMO announced that the 2024 TAT Honorary Award is bestowed to Dr. Funda Meric-Bernstam
Stacie Lindsey, CEO of Cholangiocarcinoma Foundation, shared on LinkedIn: "We are thrilled that the ESMO…
Feb 17, 2024, 16:20 |
Career
Sunil Verma: Francisco J Peña's project will focus on developing AI-based tools for precision medicine in cancer
Sunil Verma, SVP, Global Head of Oncology at AstraZeneca, shared a post by Mattias Rantalainen on…
Feb 11, 2024, 12:19 |
Blog
Benedikt Westphalen: I'm deeply grateful for the opportunity to chair the ESMO Translational Research and Precision Medicine Working
Benedikt Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, recently posted…
Feb 10, 2024, 19:00 |
Insight
Jill Feldman: We must try to be ‘precise’ with dosing so people can LIVE better
Jill Feldman shared on X/Twitter: "Thank you, Associated Press for this story on dosing! No…
Jan 27, 2024, 08:16 |
Insight
Stephen Nimer: Another important publication from Sylvester’s multiple myeloma team that will be practice changing!
Stephen Nimer, Director at Sylvester Comprehensive Cancer Center, recently shared a post by Sylvester Comprehensive…
Jan 14, 2024, 18:08 |
Blog
Vivek Subbiah: The 1st report from the Cancer Programme of the Genomes 100k project
Vivek Subbiah posted on X/Twitter: "Just out Nature Medicine: The 1st report from the Cancer Programme…
1
2
All:
132
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube